GLP-1 medications come with several side effects, leading consumers to seek natural alternatives that can complement or support their GLP-1 treatment. The gap between pharmaceutical drugs like Ozempic and Wegovy and consumer-ready food products is narrowing, with brands like Arla and Nestle working to offer functional foods that can naturally stimulate GLP-1 production and provide a sustainable solution for weight loss, appetite control, and metabolic health.
~$48B
reduction in annual F&B spending among GLP-1 users
127%
increase in high-protein food consumption by GLP-1 users
$12B
snack food market could slow down due to GLP-1 adoption.
Inside the Report:
The GLP-1 food landscape is exploding with innovations that aim to address consumer needs beyond the pharmaceutical world. This report explores:
- Companies and Startups entering the GLP-1 food landscape
- Arla Foods’ research on milk-based ingredients to promote satiety and support weight management
- Who is shaping the GLP-1 market?
Download the sample report to get detailed insights into patent trends, company strategies, enzymatic breakthroughs, and what’s next in the sugar reduction pipeline.
